SynthesisDrug safety2021
Emerging Skin Toxicities in Patients with Breast Cancer Treated with New Cyclin-Dependent Kinase 4/6 Inhibitors: A Systematic Review.
Martina Silvestri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled itcites it